Drug Type Immune cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Leukemia | Phase 1 | United States | 01 Oct 2009 | |
Multiple Myeloma | Phase 1 | United States | 01 Oct 2009 | |
Myelodysplastic Syndromes | Phase 1 | United States | 01 Oct 2009 |
Not Applicable | - | ilyomrzppt(hxitzqfdwh) = ewpwnsxdak hsegibkjvt (ppnxzeksty ) | - | 15 Jul 2004 |